Phase I, single ascending-dose trial of the tolerability and pharmacokinetics of setrobuvir in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 04 Nov 2014
At a glance
- Drugs Setrobuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Anadys Pharmaceuticals
- 31 Oct 2008 Results presented at the 59th Annual Meeting of the American Association for the Study of Liver Diseases.
- 24 Sep 2008 Status changed from recruiting to completed as reported in an Anandys media release.
- 12 Jun 2008 Status changed from planning to recruiting according to Anadys media release.